Strides Pharma Science Ltd is in the business of development and manufacturing of pharmaceutical products. The company's pharmaceutical products are sold in
Strides Pharma Science Ltd Q4FY24; 10% rise in Revenue
Categories
pharmaceuticals
Hikal Ltd Q4FY24; 6% fall in Profits
Hikal is a partner to companies in the Pharmaceuticals, Crop Protection, and Specialty Chemicals industry. The company is in the business of
Procter & Gamble Health Ltd Q4FY24; 20% fall in Profits
P&G Health Ltd (formerly Procter & Gamble td) (erstwhile Merck Limited) is engaged in the business of manufacturing and marketing of pharmaceuticals
Piramal Pharma Ltd Q4FY24; 102% rise in Profits
Piramal Pharma Limited (PPL) is part of the Piramal group of companies. The company operates through 3 major segments(1) Contract development and
Pfizer Ltd Q4FY24; 38% rise in Profits
Pfizer Ltd is engaged in manufacturing, marketing, trading and export of pharmaceutical products. It manufactures products through its own facility and also
Neuland Laboratories Ltd Q4FY24; 20% fall in Profits
Neuland Laboratories is engaged in manufacturing and selling of bulk drugs and caters to both domestic and international markets. Financial Results: Neuland
Natco Pharma Ltd Q4FY24; 40% rise in Profits
NATCO Pharma Limited (NATCO) is a vertically integrated, research and development focused pharmaceutical company engaged in developing, manufacturing, and marketing complex products
Marksans Pharma Ltd Q4FY24; 6% fall in Profits
Marksans Pharma is engaged in the Business of Formulation of pharmaceutical products. Financial Results: Marksans Pharma Ltd reported Revenues for Q4FY24 of
Aarti Drugs Ltd Q4FY24; 16% fall in Profits
Established in the year 1984 and a part of $1000 million Aarti Group of Industries, Aarti Drugs Ltd. (ADL) is engaged into
Glenmark Pharmaceuticals Ltd Q4FY24; 2% rise in Revenue
Glenmark Pharmaceuticals Ltd is a global research-led pharmaceutical company with presence across generics, Specialty and OTC business with operations in over 80
Biocon Ltd Q4FY24; 46% fall in Profits
Biocon is engaged in the business of manufacture of biotechnology products and research services.(Source : 202003-01 Annual Report Page No:195) Financial Results:
Caplin Point Laboratories Ltd Q4FY24; 20% rise in Profits
Caplin Point Laboratories Ltd is engaged in the manufacturing and sourcing of APIs, finished formulations, R&D, clinical research with presence in Latin
GMM Pfaudler Ltd Q4FY24; 12% fall in Profits
GMM Pfaudler manufactures corrosion resistant glass-lined equipments . It is a leading supplier of process equipments to the pharmaceutical and chemical industries
Gland Pharma Ltd Q4FY24; 143% rise in Profits
Established in Hyderabad, India in 1978, Gland Pharma has grown over the years from a contract manufacturer of small volume liquid parenteral
Glaxosmithkline Pharmaceuticals Ltd Q4FY24; 46% rise in Profits
GlaxoSmithKline Pharmaceuticals research, manufacture and make available a broad range of medicines and vaccines that benefit people.(Source : Company Web-site) Financial Results:
Jubilant Pharmova Ltd Q4FY24; 5% rise in Revenue
Jubilant Pharmova Ltd is an integrated global pharmaceuticals company having three business segments i.e. pharmaceuticals, contract research and development services and proprietary
Torrent Pharmaceuticals Ltd Q4FY24; 56% rise in Profits
Torrent Pharmaceuticals Ltd is one of the leading Indian Pharmaceutical Company engaged in research, development, manufacturing and marketing of generic pharmaceutical formulations.
Zydus Lifesciences Ltd Q4FY24; 248% rise in Profits
In 1995, the group was restructured and thus was formed Cadila Healthcare under the aegis of the Zydus group. From a humble
Sequent Scientific Ltd Q4FY24; 1% fall in Revenue
Sequent Scientific is India's leading animal health company, with presence in 5+ continents across 100 countries. Sequent Scientific Limited provides a wide-ranging
Neuland Laboratories Limited Q4 FY24 Earnings Conference Call Insights
Key highlights from Neuland Laboratories Limited (NEULANDLAB) Q4 FY24 Earnings Concall Financial Performance Total income for FY '24 was INR 1,511 crores,
Sanofi India Ltd Q4FY24; 28% fall in Profits
Sanofi India is engaged in Business of Manufacture and sale of pharmaceutical products. Financial Results: Sanofi India Ltd reported Revenues for Q4FY24